Progyny

Progyny

Yahoo Finance • 2 days ago

Q2 watchlist: Healthcare stocks with perfect EPS revision scores

[Heart Health Concept] Eoneren/E+ via Getty Images As Q2 2026 earnings season approaches, healthcare stocks are drawing investor attention as markets assess demand across care delivery, diagnostics, life sciences, pharmaceuticals, medical... Full story

Yahoo Finance • 4 days ago

Progyny (PGNY): Buy, Sell, or Hold Post Q1 Earnings?

Progyny (PGNY): Buy, Sell, or Hold Post Q1 Earnings? Progyny trades at $31.10 per share and has stayed right on track with the overall market, gaining 13.4% over the last six months. At the same time, the S&P 500 has returned 9%. Is now... Full story

Yahoo Finance • 6 days ago

Progyny (PGNY) Earns Higher Price Target After Management Meetings

With EPS growth for the next five years forecasted at 40.83%, Progyny, Inc. (NASDAQ:PGNY) is among the 12 Best Quality Stocks to Buy and Hold for the Next Decade. On June 22, Truist raised its price target on Progyny, Inc. (NASDAQ:PGNY) t... Full story

Yahoo Finance • 10 days ago

Q1 Earnings Highs And Lows: UnitedHealth (NYSE:UNH) Vs The Rest Of The Health Insurance Providers Stocks

Q1 Earnings Highs And Lows: UnitedHealth (NYSE:UNH) Vs The Rest Of The Health Insurance Providers Stocks As the Q1 earnings season wraps, let's dig into this quarter's best and worst performers in the health insurance providers industry,... Full story

Yahoo Finance • 17 days ago

What Does the Sale of Progyny Shares by the CFO Mean for Investors?

Key Points CFO Mark Livingston sold 8,275 shares for a transaction value of ~$211,000 on May 20, 2026. This represented 9.47% of Livingston's direct holdings, reducing his direct position to 79,063 shares. The transaction involved only di... Full story

Yahoo Finance • last month

Progyny (PGNY) Authorizes $200M Share Repurchase Program

Progyny, Inc. (NASDAQ:PGNY) is one of the 15 Most Promising Stocks to Buy Right Now. On May 26, 2026, Progyny, Inc. (NASDAQ:PGNY) announced that its Board of Directors approved a share repurchase program to buy back up to $200 million of... Full story

Yahoo Finance • last month

A Progyny (PGNY) Insider Sold 5,500 Shares for $137,000

Progyny(NASDAQ:PGNY) delivers fertility benefits to major employers; a key insider recently trimmed their stake, according to SEC filings. Kevin K. Gordon, Director at Progyny, reported the sale of 5,500 shares of common stock for a trans... Full story

Yahoo Finance • 2 months ago

Smart ring firm Ōura confidentially files for U.S. IPO (update)

[Wooden blocks with the word IPO and virtual stock graph. Initial Public Offering or stock launch concept.] fadfebrian Smart ring maker Ōura Health Oy, which competes with tech heavyweights such as Apple (AAPL [https://seekingalpha.com/sy... Full story

Yahoo Finance • 2 months ago

StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Guggenheim upgraded StubHub (STUB) to... Full story

Yahoo Finance • 2 months ago

Trump administration proposes easier employer access to IVF benefits

[Writing note showing Benefits. Business photo showcasing hike in allowance for senior employees of the company written on Wood Piece holding by man on the Blue Jeans background.] Artur/iStock via Getty Images The Trump administration sai... Full story

Yahoo Finance • 2 months ago

Progyny anticipates 2026 revenue of $1.365B-$1.405B while raising adjusted EBITDA to $232M-$244M

Earnings Call Insights: Progyny (PGNY) Q1 2026 MANAGEMENT VIEW * “We’re pleased to report that we’ve had a good start to the year with record first quarter revenue coming in at the higher end of our expectations. And net income, earnin... Full story

Yahoo Finance • 3 months ago

Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan

NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announces Progyny Select, the industry’s first fully insured, comprehensive supplemental fe... Full story

Yahoo Finance • 3 months ago

2 Reasons to Sell PGNY and 1 Stock to Buy Instead

Although the S&P 500 is down 2.1% over the past six months, Progyny’s stock price has fallen further to $17.17, losing shareholders 16.6% of their capital. This was partly driven by its softer quarterly results and might have investors con... Full story

Yahoo Finance • 4 months ago

Progyny CEO Details Utilization Trends, Forecasting and Progyny Select Fully Insured Rollout at Conference

Progyny logo Key Points Utilization, not eligible lives: Anevski said Progyny focuses on actual benefit use rather than fluctuating eligibility counts, noting utilization has been stable historically around ~1.03%–1.09%. Progyny Select r... Full story

Yahoo Finance • 4 months ago

Barclays Raises Hims & Hers (HIMS) Target to $29 After Novo Deal Clears Legal Overhang — Canaccord Cuts Progyny (PGNY) on Cautious 2026 Outlook

Quick Read Hims & Hers Health (HIMS) reached $2.347 billion in full-year revenue, up 59% year-over-year, with a subscriber base crossing 2.5 million and monthly revenue per subscriber at $83. Progyny (PGNY) posted $1.289 billion in full-y... Full story

Yahoo Finance • 4 months ago

Centene tumbles on ACA warnings but leads managed care with top Buy Quant rating

[medicare word written on wood block and stethoscope on a pink background] Alena Zharava/iStock via Getty Images Centene (CNC [https://seekingalpha.com/symbol/CNC]) shares tumbled about 11% Tuesday after CEO Sarah London warned at the Bar... Full story

Yahoo Finance • 4 months ago

Progyny, Inc. Executives to Participate in Upcoming Investor Conferences

NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that several members of its leadership team will participate in upcoming investor... Full story

Yahoo Finance • 5 months ago

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report

NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period and full year ended December 31, 2025,... Full story

Yahoo Finance • 7 months ago

Has Progyny’s 85.7% Surge in 2025 Already Priced In Its Growth Story?

If you are wondering whether Progyny's recent run makes it attractive at today’s price, or if you have already missed the upside, this breakdown will help you understand what the market is really pricing in. Progyny has quietly put up a st... Full story

Yahoo Finance • 8 months ago

Galvanize Therapeutics Appoints Laura Francis to its Board of Directors

REDWOOD CITY, Calif., Nov. 24, 2025 /PRNewswire/ -- Galvanize ("Galvanize") Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease, today ann... Full story